HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suppression of Torsades de Pointes with verapamil in patients with atrio-ventricular block.

Abstract
Experimental data have suggested a relation between Torsades de Pointes and early post-depolarization (EPD). We have studied the effect of intravenous verapamil in three patients with atrioventricular block (AVB) and Torsades de Pointes (TP), to obtain indirect evidence of slow membrane channel involvement in the TP mechanism. In two cases TP were completely suppressed and in one there was marked, albeit partial, suppression. In two cases verapamil did not shorten QT, while in the third suppression verapamil was related to junctional escape acceleration and QT shortening. In one of the cases where QT was not changed, the abolition of long pauses may have played a role in TP suppression. The affect of verapamil on TP in our patients is consistent with a combination of mechanisms, including direct membrane effects (EPD inhibition) and junctional pacemaker acceleration. Verapamil might be of therapeutic value in this clinical setting.
AuthorsF G Cosio, A Goicolea, M López Gil, C Kallmeyer, J L Barroso
JournalEuropean heart journal (Eur Heart J) Vol. 12 Issue 5 Pg. 635-8 (May 1991) ISSN: 0195-668X [Print] England
PMID1874264 (Publication Type: Journal Article)
Chemical References
  • Verapamil
Topics
  • Aged
  • Electrocardiography
  • Female
  • Heart Block (complications, drug therapy)
  • Humans
  • Male
  • Torsades de Pointes (complications, drug therapy, physiopathology)
  • Verapamil (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: